Results from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received chemotherapy before surgery to remove advanced squamous cell-type cancer of the nose ...
Sep 10, 2024
0
1
Cholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in people older than age 50. It is often diagnosed when it is advanced, making successful treatment ...
Sep 10, 2024
0
0
For adults with hepatocellular carcinoma or liver metastases, low-dose liver radiotherapy plus best supportive care improve pain compared with best supportive care alone, according to a study published online Sept. 5 in The ...
Sep 10, 2024
0
0
Erik Almazan, MD, of the Department of Medicine at Brigham and Women's Hospital and Raymond T. Chung, MD, of the Liver Center at Massachusetts General Hospital, are the authors of a paper titled "Association of Statin, Metformin, ...
Sep 9, 2024
0
0
Women with hepatocellular carcinoma (HCC) are less likely to receive a deceased-donor liver transplant (DDLT) and more likely to die while wait-listed than men, according to a study published online Sept. 4 in JAMA Surgery.
Sep 9, 2024
0
0
Assistant Professor Keiko Hatanaka of Toho University, a Ph.D. student of Tokyo Medical and Dental University (TMDU), in collaboration with Professors Yoshiko Sasaki and Makoto Tanaka of Tokyo Medical and Dental University ...
Sep 5, 2024
0
0
A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers. The findings, published in ...
Sep 4, 2024
1
0
A new editorial was published in Oncotarget, titled "Beyond pixels: Graph filtration learning unveils new dimensions in hepatocellular carcinoma imaging."
Aug 30, 2024
0
0
Pediatric hepatocellular carcinoma (HCC) and fibrolamellar carcinoma are rare, aggressive forms of liver cancer that typically affect adolescents and young adults. Although some immunotherapy drugs are approved by the Food ...
Aug 30, 2024
0
30
"Total bunk." That was the first thought that crossed Timothy Caulfield's mind when he heard about the latest misinformation trend about sunscreen. Then the anger and frustration hit.
Aug 29, 2024
0
7
